At The Ottawa Hospital, we’ve pushed the boundaries of healthcare and research to earn recognition as one of the top research hospitals in Canada. In the last three years alone, our researchers have been actively involved in nearly 6,000 collaborative projects with partners in every Canadian province and territory and 151 countries. With your help, we’re bringing life-changing research and care to patients not just in Ottawa but across Canada and around the world.

We are a global research powerhouse.

THANKS TO YOU.

We are a global research powerhouse — thanks to you.

We are a global research powerhouse — thanks to you.

At The Ottawa Hospital, we’ve pushed the boundaries of healthcare and research to earn recognition as one of the top research hospitals in Canada. In the last three years alone, our researchers have been actively involved in nearly 6,000 collaborative projects with partners in every Canadian province and territory and 151 countries. With your help, we’re bringing life-changing research and care to patients not just in Ottawa but across Canada and around the world.

International Space Station
International Space Station

OUTER SPACE TRAVEL

USA, Canada, Japan, Europe
Researchers at The Ottawa Hospital are leading a study on the International Space Station, which is providing world-first insights into how space travel affects astronaut bone marrow and blood cells.

International Space Station

CAR-T IMMUNOTHERAPY

In partnership with BC Cancer, we are leading the first made-in-Canada CAR-T cell research program and clinical trial. CAR-T therapy is a highly personalized form of cancer immunotherapy that is proving to be a game-changer. We also lead Canada’s Immunotherapy Network, BioCanRx.

REGENERATIVE MEDICINE

We are a global pioneer in using stem cell transplantation to “reset” the immune system in people with severe MS. This groundbreaking treatment, is now a standard of care across North America. We are also home to Canada’s Stem Cell Network, the Sprott Centre for Stem Cell Research and the Sinclair Centre for Regenerative Medicine.

TUBERCULOSIS

Our researchers are working with Nunavut Tunngavik and the Government of Nunavut on research projects to improve the prevention, diagnosis, and treatment of tuberculosis which is at least 300 times more common among Inuit in Nunavut compared to the rest of Canada.

VACCINE AND BIOMANUFACTURING

Our Biotherapeutics Manufacturing Centre is the most experienced and successful facility of its kind. We are collborating across Canada, North America, Europe and Asia to develop and manufacture products like vaccines, cancer-fighting viruses, gene therapies, stem cell therapies and more.

PARKINSON'S

We are working with multiple centres across Europe (Germany, Spain, France, Ireland, Czech Republic) to pilot a personalized approach for Parkinson's care.

PARKINSON'S

We are working with multiple centres across Europe (Germany, Spain, France, Ireland, Czech Republic) to pilot a personalized approach for Parkinson's care.

PARKINSON'S

We are working with multiple centres across Europe (Germany, Spain, France, Ireland, Czech Republic) to pilot a personalized approach for Parkinson's care.

PATIENT DECISION AIDS

The Ottawa Hospital is home to the largest repository and research program in the world of patient decision aids. We are working with colleagues in the USA and around the world to develop award-winning interactive tools that help people weigh treatment and screening options.

PATIENT DECISION AIDS

The Ottawa Hospital is home to the largest repository and research program in the world of patient decision aids. These award-winning interactive tools help people weigh treatment and screening options.

BLOOD CLOTS

Researchers at The Ottawa Hospital co-lead the Canadian Venous Thromboembolism Research Network (CanVECTOR) together with colleagues in Montreal. This network brings 28 research centres across the country together to determine the best approaches for treatment and prevention of dangerous blood clots in the legs and lungs.

RETHINKING CLINICAL TRIALS

We are leading the largest pragmatic cancer clinical trials program in Canada (REaCT), with more than 4,000 patients participating in 24 clinical trials at 16 centres in Canada.

EMERGENCY MEDICINE

If you’ve ever been treated in an emergency department anywhere in the world, chances are your healthcare provider used a clinical decision rule developed at The Ottawa Hospital to help diagnose you. In fact, three of the top five rules recommended for U.S. emergency departments were developed in Ottawa.

COVID-19

We co-lead the award-winning COVID Evidence Network (COVID-END), which produces reliable and timely COVID-19 evidence summaries for decision makers in more than 30 countries in North America, South America, Africa, Europe and Asia.

COVID-19

We co-lead the award-winning COVID Evidence Network (COVID-END), which produces reliable and timely COVID-19 evidence summaries for decision makers in more than 30 countries in North America, South America, Africa, Europe and Asia.

ALZHEIMER'S

We are playing a major role in a massive collaborative research incubator that is testing non-drug, care-based interventions for Alzheimer’s and dementia.

STROKE

We are working with colleagues from the Hotchkiss Brain Institute (HBI) to help predict which ischemic stroke patients would benefit the most from a clot-busting drug. The findings from this study will change how stroke doctors across Canada, and around the world, make treatment decisions.

HIV

We co-lead the CanCURE research network, which aims to eliminate HIV-infected cells that can hide from current treatments. This research has the potential to result in a true cure for HIV.

USING BIG DATA TO HELP THE SMALLEST BABIES​

We are working with colleagues in Kenya, Uganda and around the world to develop a simple blood test and mathematical model to accurately identify preterm babies without ultrasound in low-resource countries.

USING BIG DATA TO HELP THE SMALLEST BABIES​

We are working with colleagues in China and around the world to develop a simple blood test and mathematical model to accurately identify preterm babies without ultrasound in low-resource countries.

USING BIG DATA TO HELP THE SMALLEST BABIES​

We are working with colleagues in the Phillipines and around the world to develop a simple blood test and mathematical model to accurately identify preterm babies without ultrasound in low-resource countries.

USING BIG DATA TO HELP THE SMALLEST BABIES​

We are working with colleagues in Bangladesh and around the world to develop a simple blood test and mathematical model to accurately identify preterm babies without ultrasound in low-resource countries.

USING BIG DATA TO HELP THE SMALLEST BABIES​

We are working with colleagues in Zambia, Zimbabwe, and around the world to develop a simple blood test and mathematical model to accurately identify preterm babies without ultrasound in low-resource countries.

PATIENT DECISION AIDS

The Ottawa Hospital is home to the largest repository and research program in the world of patient decision aids. We are working with colleagues in Denmark and around the world to develop award-winning interactive tools that help people weigh treatment and screening options.

PATIENT DECISION AIDS

The Ottawa Hospital is home to the largest repository and research program in the world of patient decision aids. We are working with colleagues in Australia and around the world to develop award-winning interactive tools that help people weigh treatment and screening options.

PARKINSON'S

We are working with multiple centres across Europe (Germany, Spain, France, Ireland, Czech Republic) to pilot a personalized approach for Parkinson's care.

DIGITAL HEALTH

We are one of the first hospitals in the world to partner with Sheba Medical Centre and the ARC (Accelerate, Redesign, Collaborate) Center for Digital Innovation in Isreal.

BLOOD CLOTS

Researchers at The Ottawa Hospital co-lead the Canadian Venous Thromboembolism Research Network (CanVECTOR) together with colleagues in Montreal. This network brings 28 research centres across the country together to determine the best approaches for treatment and prevention of dangerous blood clots in the legs and lungs.

BLOOD CLOTS

Researchers at The Ottawa Hospital co-lead the Canadian Venous Thromboembolism Research Network (CanVECTOR) together with colleagues in Montreal. This network brings 28 research centres across the country together to determine the best approaches for treatment and prevention of dangerous blood clots in the legs and lungs.

VACCINE AND BIOMANUFACTURING

Our Biotherapeutics Manufacturing Centre is the most experienced and successful facility of its kind. We are collborating across Canada, North America, Europe and Asia to develop and manufacture products like vaccines, cancer-fighting viruses, gene therapies, stem cell therapies and more.

VACCINE AND BIOMANUFACTURING

Our Biotherapeutics Manufacturing Centre is the most experienced and successful facility of its kind. We are collborating across Canada, North America, Europe and Asia to develop and manufacture products like vaccines, cancer-fighting viruses, gene therapies, stem cell therapies and more.

COVID-19

We co-lead the award-winning COVID Evidence Network (COVID-END), which produces reliable and timely COVID-19 evidence summaries for decision makers in more than 30 countries in North America, South America, Africa, Europe and Asia.

COVID-19

We co-lead the award-winning COVID Evidence Network (COVID-END), which produces reliable and timely COVID-19 evidence summaries for decision makers in more than 30 countries in North America, South America, Africa, Europe and Asia.

COVID-19

We co-lead the award-winning COVID Evidence Network (COVID-END), which produces reliable and timely COVID-19 evidence summaries for decision makers in more than 30 countries in North America, South America, Africa, Europe and Asia.

Number of collaborative projects

CAR-T IMMUNOTHERAPY

Ottawa, Vancouver, Victoria, Toronto, Winnipeg
In partnership with BC Cancer, we are leading the first made-in-Canada CAR-T cell research program and clinical trial. CAR-T therapy is a highly personalized form of cancer immunotherapy that is proving to be a game-changer. We also lead Canada’s Immunotherapy Network, BioCanRx. 

REGENERATIVE MEDICINE

Across Canada
We are a global pioneer in using stem cell transplantation to “reset” the immune system in people with severe MS. This groundbreaking treatment, is now a standard of care across North America. We are also home to Canada’s Stem Cell Network, the Sprott Centre for Stem Cell Research and the Sinclair Centre for Regenerative Medicine.

VACCINE AND BIOMANUFACTURING

Across Canada, North America, Europe, Asia

Our Biotherapeutics Manufacturing Centre is the most experienced and successful facility of its kind. Products include vaccines, cancer-fighting viruses, gene therapies, stem cell therapies and more.

TUBERCULOSIS

Nunavut

Our researchers are working with Nunavut Tunngavik and the Government of Nunavut on research projects to improve the prevention, diagnosis, and treatment of tuberculosis which is at least 300 times more common among Inuit in Nunavut compared to the rest of Canada.

DIGITAL HEALTH

Israel

We are one of the first hospitals in the world to partner with Sheba Medical Centre and the ARC (Accelerate, Redesign, Collaborate) Center for Digital Innovation.

PARKINSON'S

Ottawa, British Columbia, Germany, Spain, France, Ireland, Czech Republic, USA

We are working with multiple centres across Europe to pilot a personalized approach for Parkinson’s care.

Could Parkinson’s research change what we know about the brain? At The Ottawa Hospital, we’re pushing to demystify Parkinson’s disease. Find out how.

PATIENT DECISION AIDS

Canada, USA, Denmark, Australia
The Ottawa Hospital is home to the largest repository and research program in the world of patient decision aids. These award-winning interactive tools help people weigh treatment and screening options.

USING BIG DATA TO HELP THE SMALLEST BABIES

Ottawa, Uganda, China, Philippines, USA, Zambia, Bangladesh, Kenya, Zimbabwe

We are working with colleagues around the world to develop a simple blood test and mathematical model to accurately identify preterm babies without ultrasound in low-resource countries. 

BLOOD CLOTS

Across Canada, France, Netherlands Australia

Researchers at The Ottawa Hospital co-lead the Canadian Venous Thromboembolism Research Network (CanVECTOR) together with colleagues in Montreal. This network brings 28 research centres across the country together to determine the best approaches for treatment and prevention of dangerous blood clots in the legs and lungs.

USING BIG DATA TO HELP THE SMALLEST BABIES​

We are working with colleagues in Kenya, Uganda and around the world to develop a simple blood test and mathematical model to accurately identify preterm babies without ultrasound in low-resource countries.

USING BIG DATA TO HELP THE SMALLEST BABIES​

We are working with colleagues in China and around the world to develop a simple blood test and mathematical model to accurately identify preterm babies without ultrasound in low-resource countries.

USING BIG DATA TO HELP THE SMALLEST BABIES​

We are working with colleagues in the Phillipines and around the world to develop a simple blood test and mathematical model to accurately identify preterm babies without ultrasound in low-resource countries.

USING BIG DATA TO HELP THE SMALLEST BABIES​

We are working with colleagues in Bangladesh and around the world to develop a simple blood test and mathematical model to accurately identify preterm babies without ultrasound in low-resource countries.

USING BIG DATA TO HELP THE SMALLEST BABIES​

We are working with colleagues in Zambia, Zimbabwe, and around the world to develop a simple blood test and mathematical model to accurately identify preterm babies without ultrasound in low-resource countries.

PATIENT DECISION AIDS

The Ottawa Hospital is home to the largest repository and research program in the world of patient decision aids. We are working with colleagues in Denmark and around the world to develop award-winning interactive tools that help people weigh treatment and screening options.

PATIENT DECISION AIDS

The Ottawa Hospital is home to the largest repository and research program in the world of patient decision aids. We are working with colleagues in Australia and around the world to develop award-winning interactive tools that help people weigh treatment and screening options.

PARKINSON'S

We are working with multiple centres across Europe (Germany, Spain, France, Ireland, Czech Republic) to pilot a personalized approach for Parkinson's care.

DIGITAL HEALTH

We are one of the first hospitals in the world to partner with Sheba Medical Centre and the ARC (Accelerate, Redesign, Collaborate) Center for Digital Innovation in Isreal.

BLOOD CLOTS

Researchers at The Ottawa Hospital co-lead the Canadian Venous Thromboembolism Research Network (CanVECTOR) together with colleagues in Montreal. This network brings 28 research centres across the country together to determine the best approaches for treatment and prevention of dangerous blood clots in the legs and lungs.

BLOOD CLOTS

Researchers at The Ottawa Hospital co-lead the Canadian Venous Thromboembolism Research Network (CanVECTOR) together with colleagues in Montreal. This network brings 28 research centres across the country together to determine the best approaches for treatment and prevention of dangerous blood clots in the legs and lungs.

VACCINE AND BIOMANUFACTURING

Our Biotherapeutics Manufacturing Centre is the most experienced and successful facility of its kind. We are collborating across Canada, North America, Europe and Asia to develop and manufacture products like vaccines, cancer-fighting viruses, gene therapies, stem cell therapies and more.

VACCINE AND BIOMANUFACTURING

Our Biotherapeutics Manufacturing Centre is the most experienced and successful facility of its kind. We are collborating across Canada, North America, Europe and Asia to develop and manufacture products like vaccines, cancer-fighting viruses, gene therapies, stem cell therapies and more.

COVID-19

We co-lead the award-winning COVID Evidence Network (COVID-END), which produces reliable and timely COVID-19 evidence summaries for decision makers in more than 30 countries in North America, South America, Africa, Europe and Asia.

COVID-19

We co-lead the award-winning COVID Evidence Network (COVID-END), which produces reliable and timely COVID-19 evidence summaries for decision makers in more than 30 countries in North America, South America, Africa, Europe and Asia.

COVID-19

We co-lead the award-winning COVID Evidence Network (COVID-END), which produces reliable and timely COVID-19 evidence summaries for decision makers in more than 30 countries in North America, South America, Africa, Europe and Asia.

Number of collaborative projects

RETHINKING CLINICAL TRIALS

Ottawa, Toronto, Thunder Bay, Kingston, Windsor, London, Regina, Saskatoon

We are leading the largest pragmatic cancer clinical trials program in Canada (REaCT), with more than 4,000 patients participating in 24 clinical trials at 16 centres in Canada.

EMERGENCY MEDICINE

Worldwide
If you’ve ever been treated in an emergency department anywhere in the world, chances are your healthcare provider used a clinical decision rule developed at The Ottawa Hospital to help diagnose you. In fact, three of the top five rules recommended for U.S. emergency departments were developed in Ottawa.

COVID-19

North America, South America, Africa, Europe, Asia

We co-lead the award-winning COVID Evidence Network (COVID-END), which produces reliable and timely COVID-19 evidence summaries for decision makers in more than 30 countries.

ALZHEIMER’S

USA

We are playing a major role in a massive collaborative research incubator that is testing non-drug, care-based interventions for Alzheimer’s and dementia.

STROKE

Ottawa, Calgary and across Canada

We are working with colleagues from the Hotchkiss Brain Institute (HBI) to help predict which ischemic stroke patients would benefit the most from a clot-busting drug. The findings from this study will change how stroke doctors across Canada, and around the world, make treatment decisions.

HIV

Ottawa, Montreal, Laval, Winnipeg

We co-lead the CanCURE research network, which aims to eliminate HIV-infected cells that can hide from current treatments. This research has the potential to result in a true cure for HIV.

It’s time to take research to unprecedented heights

In the last 20 years, we’ve pushed the boundaries of healthcare and research — changing and saving lives all over the world.

Our experts predict more research and clinical breakthroughs will happen in the next ten years than have happened over the last 50. And with your help, more of them will happen here at our hospital.

This means improved treatments and novel therapies — and greater hope for us all.

Learn more about the Campaign to Create Tomorrow and the World-Leading Research taking place at our hospital.

Through our unique collaborative model of clinicians and researchers working side-by-side, we will bring groundbreaking discoveries to patients in Ottawa — and around the world.
Learn More